does tirzepatide help with addiction A turning point in psychiatry? | School of Public Health Early signs show popular weight

Novo Nordisk's SELECT trial published in 2023, set a high standard by demonstrating that Wegovy-induced weight loss led to a statistically significant 20% reduction in a composite endpoint comprising cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke among overweight or obese patients with prior cardiovascular disease

The injection is absorbed directly through tissue under the skin

Ling ZN, Jiang YF, Ru JN, Lu JH, Ding B, Wu J

Consequently, the potential for this class of drugs is enormous and may be a paradigm shift not only for the management of obesity but also for several other conditions

What happens to side effects if I stay on tirzepatide for more than a year